Lumos Pharma | 4: Statement of changes in beneficial ownership of securities-Officer Schuchart Aaron
Apr 3 17:16 ET
Lumos Pharma | 4: Statement of changes in beneficial ownership of securities-Officer Hawkins Richard J
Apr 3 17:16 ET
Lumos Pharma | 4: Statement of changes in beneficial ownership of securities-Officer McKew John C.
Apr 3 17:16 ET
Lumos Pharma | 4: Statement of changes in beneficial ownership of securities-Officer POWERS BRADLEY J
Apr 3 17:15 ET
Lumos Pharma | 4: Statement of changes in beneficial ownership of securities-Officer Lawley Lori D
Apr 3 17:14 ET
Lumos Pharma | 4: Statement of changes in beneficial ownership of securities-Officer Pitukcheewanont Pisit Duke
Apr 3 17:13 ET
Lumos Pharma | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-THE GOLDMAN SACHS GROUP, INC.(5.1 %),GOLDMAN SACHS & CO. LLC(5.1 %)
Feb 9 19:15 ET
Lumos Pharma | 4: Statement of changes in beneficial ownership of securities-Officer McKew John C.
Feb 7 17:27 ET
Lumos Pharma | SC 13G: Statement of acquisition of beneficial ownership by individuals-Wells Fargo & Company (b) Tax ID(5.3%)
Feb 6 10:02 ET
Lumos Pharma | 4: Statement of changes in beneficial ownership of securities-Officer McKew John C.
Feb 5 17:59 ET
Lumos Pharma | 4: Statement of changes in beneficial ownership of securities-Officer Hawkins Richard J
Feb 5 17:58 ET
Lumos Pharma | 4: Statement of changes in beneficial ownership of securities-Officer Lawley Lori D
Feb 5 17:58 ET
Lumos Pharma | 4: Statement of changes in beneficial ownership of securities-Officer Schuchart Aaron
Feb 5 17:54 ET
Lumos Pharma | 4: Statement of changes in beneficial ownership of securities-Officer POWERS BRADLEY J
Feb 5 17:54 ET
Lumos Pharma | 3: Initial statement of beneficial ownership of securities-Officer Pitukcheewanont Pisit Duke
Jan 10 00:00 ET
Lumos Pharma | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Clarus Lifesciences III, L.P.(4.9%),Clarus Ventures III GP, L.P.(4.9%), etc.
Nov 29, 2023 16:30 ET
Lumos Pharma | 4: Statement of changes in beneficial ownership of securities-Officer McKew John C.
Aug 3, 2023 16:58 ET
Lumos Pharma | 4: Statement of changes in beneficial ownership of securities-Chief Financial Officer Lawley Lori D
Aug 3, 2023 16:58 ET
Lumos Pharma | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Daniel Farb(4.90%)
Jun 20, 2023 06:05 ET
Lumos Pharma | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Daniel Farb(6.08%)
Jun 2, 2023 11:14 ET
No Data
No Data